A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

NCT03257631 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Nervous System Neoplasms
Medulloblastoma

Interventions

DRUG: Pomalidomide
DRUG: Pomalidomide

Sponsor

Celgene